SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Thursday reported a loss of $7.7 million in its second quarter.
The San Diego-based company said it had a loss of 16 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The biopharmaceutical company posted revenue of $5.8 million in the period, matching Street forecasts.
In the final minutes of trading on Thursday, the company's shares hit 97 cents. A year ago, they were trading at $3.45.